Characteristic infectivity of Sporothrix schenckii to mice depending on routes of infection and inherent fungal pathogenicity.

Abstract

Isolates of Sporothrix schenckii were examined for their infectivity in BALB/c mice. The mice were injected with yeast forms of S. schenckii isolates differing in clinical source (human cutaneous lesions and pulmonary lesions), and fungal growth was determined at intervals in the footpad and visceral organs. After subcutaneous injection of approximately 10 colony forming units (cfu) of S. schenckii into the footpad, locally restricted fungal infection developed gradually. At the peak of the infection (3-4 weeks post-inoculation), viable fungal counts reached 102-106 cfu/footpad. Dissemination to other tissues and visceral organs was not observed. After intravenous or intraperitoneal injection of 106 cfu of yeast forms, three of four isolates from cutaneous sporotrichosis were unable to establish infection and were eliminated from blood and visceral organs. The development of systemic infection was observed only with S. schenckii isolates obtained from the human lung lesion. Thus, inherent properties of each clinical isolate and routes of infection were shown to be critical for the establishment of systemic infection in spite of the remarkably strong infectivity of S. schenckii to the cutaneous tissue.

• Authors: T Tachibana, T Matsuyama, M Mitsuyama
• Journal: Medical mycology (Med Mycol) Vol. 36 Issue 1 Pg. 21-7 (Feb 1998) ISSN: 1369-3786 [Print] England
• PMID: 9776808 (Publication Type: Journal Article)

Topics

• Animals
• Dermatomycoses (microbiology, pathology, physiopathology)
• Humans
• Injections, Intraperitoneal
• Injections, Intravenous
• Injections, Subcutaneous
• Lung Diseases, Fungal (microbiology)
• Mice
• Mice, Inbred BALB C
• Mycoses (pathology, physiopathology)
• Sporothrix (growth & development, isolation & purification, pathogenicity)
• Time Factors
• Virulence